ChromaDex Corp (NAS:CDXC)
$ 2.79 -0.14 (-4.78%) Market Cap: 210.75 Mil Enterprise Value: 197.14 Mil PE Ratio: 0 PB Ratio: 7.15 GF Score: 78/100

Q3 2022 Chromadex Corp Earnings Call Transcript

Nov 02, 2022 / 08:30PM GMT
Release Date Price: $1.67 (+1.83%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to ChromaDex Corporation's Third Quarter 2022 Conference Call. My name is Joel, and I will be the conference operator today. (Operator Instructions). This afternoon, ChromaDex issued a news release announcing the company's financial results for the third quarter of 2022. If you have not reviewed this information, both are available within the Investor Relations section of ChromaDex's website at www.chromadex.com. I would now like to turn the conference call over to Tom Shumaker, LifeSci Advisors Agency IR Counsel for ChromaDex. Please go ahead, Mr. Shumaker.

Tom Shumaker
ChromaDex Corporation - MD of LifeSci Advisors

Thank you. Good afternoon, and welcome to ChromaDex Corporation's Third Quarter 2022 Results Investor Call. With us today are ChromaDex's Chief Executive Officer, Rob Fried; Interim Chief Financial Officer, Brianna Gerber; and Senior Vice President of Scientific and Regulatory Affairs, Dr. Andrew Shao, who will join the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot